{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    9,
    20,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 2.2, 8.5.4 - Secondary Objectives/Analysis",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Changed KCCQ score reporting from clinical/overall to total symptom score."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 1.4, 2.4, 4, 5.8 - Study Design and Objectives",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of an Echocardiographic Sub-study including objectives and procedures."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 2.3, 6.3.1, 6.3.2.6 - Safety Objectives and AE Collection",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Expanded AE collection to include events preceding lower limb amputation."
      },
      {
        "id": "impact_4",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 3.2 - Exclusion Criteria",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Clarified exclusion criteria 3 and 13; extended contraceptive requirements for criterion 16."
      },
      {
        "id": "impact_5",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 5.1.1, 5.1.4 - Endpoint Reporting",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Removed adjudication requirement for eGFR decline renal endpoints."
      },
      {
        "id": "impact_6",
        "amendmentId": "amend_v2.0",
        "affectedSection": "Section 6.4.1 - Reporting of SAEs",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Limited event types withheld from health authority reporting to HF and fatal AEs only."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_v2.0",
        "reasonText": "Discussion with regulatory authorities regarding lower limb amputation risks.",
        "category": "Regulatory",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_v2.0",
        "reasonText": "Feedback from regulatory authorities and harmonization with the Informed Consent Form (ICF).",
        "category": "Regulatory",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_v2.0",
        "reasonText": "Endpoint criteria did not justify the adjudication of eGFR decline events.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_4",
        "amendmentId": "amend_v2.0",
        "reasonText": "Simplify SAE reporting and minimize risk of incorrectly withholding renal AEs of interest.",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_5",
        "amendmentId": "amend_v2.0",
        "reasonText": "Correcting typos, cross-references, and alignment with AstraZeneca House style.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_v2.0",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "2.2",
        "beforeText": "KCCQ clinical/overall symptom score",
        "afterText": "KCCQ total symptom score",
        "summary": "Updated the specific KCCQ score used for secondary variable analysis."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_v2.0",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "5.8",
        "afterText": "Echocardiographic Sub-study",
        "summary": "Added a new section to capture information related to the echocardiographic sub-study."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_v2.0",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "6.3.2.6",
        "beforeText": "AEs leading to amputation",
        "afterText": "AEs leading to amputation and AEs leading to a risk for lower limb amputations (preceding events)",
        "summary": "Expanded safety reporting to include events that place a patient at risk for amputation."
      },
      {
        "id": "change_4",
        "amendmentId": "amend_v2.0",
        "changeType": "Deletion",
        "instanceType": "StudyChange",
        "sectionNumber": "5.1.4",
        "beforeText": "Requirement of adjudicating potential endpoints related to eGFR decline",
        "afterText": "Removed requirement",
        "summary": "Eliminated the need for adjudication for specific renal decline endpoints."
      },
      {
        "id": "change_5",
        "amendmentId": "amend_v2.0",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2.7",
        "beforeText": "Not specified",
        "afterText": "Investigator responsibility regarding standard of care treatment after IP discontinuation",
        "summary": "Clarified post-IP treatment responsibilities for investigators."
      }
    ],
    "summary": {
      "impactCount": 6,
      "reasonCount": 5,
      "changeCount": 5
    }
  }
}